Abstract
Objective: To examine the effect of oestrogen alone and in combination with progestin on the risk of low-energy, hip, wrist, and upper arm fractures. Additionally, to examine to what extent previous use, duration of use as well as recency of discontinuation of hormone replacement therapy (HRT) influences the fracture risk. Design: Prospective cohort study. Setting: The Danish Nurse Cohort Study Participants: 7082 female nurses aged 50–69, who completed a questionnaire on lifestyle and use of HRT in 1993. Outcome measures: Self-reported low-energy, hip, wrist, and upper arm fractures between 1993–1999 obtained at a re-examination in 1999. Results: Compared to never users, current users of HRT, either oestrogen alone or combined with progestin, had a lower risk of low-energy, hip, wrist, and upper arm fractures (hazard ratio 0.60, 0.39–0.93 and hazard ratio 0.44, 0.30–0.66, respectively). The protective effect of HRT appeared to be significantly restricted to users who used the therapy for 10 years or more (hazard ratio 0.27, 0.14–0.51). Women who previously used hormones experienced no protective effect on fracture risk regardless of duration of therapy and recency of discontinuation. Conclusion: Only long-term HRT (10 years or more) offers a protective effect against low energy, hip, wrist, and upper arm fractures. In women with risk factors or established osteoporosis, benefits and risks of this therapy should be balanced when considering its use as a first line treatment for prevention of these fractures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L Nilas C Christiansen (1987) ArticleTitleBone mass and its relationship to age and the menopause J Clin Endocrinol Metab 65 697–702 Occurrence Handle3654915 Occurrence Handle1:STN:280:DyaL1c%2FgvVaitQ%3D%3D Occurrence Handle10.1210/jcem-65-4-697
JA. Kanis (1993) ArticleTitleThe incidence of hip fracture in Europe Osteoporosis Int Suppl. 1 10–15 Occurrence Handle10.1007/BF01621853
C Christiansen MS Christensen P McNair C Hagen K-E Stocklund I Transb¢l (1980) ArticleTitlePrevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 10 273–279 Occurrence Handle6253303 Occurrence Handle1:STN:280:DyaL3M%2FksVWntw%3D%3D Occurrence Handle10.1111/j.1365-2362.1980.tb00033.x
P Eiken N Kolthoff NS Nielsen (1996) ArticleTitleEffect of 10 year’s hormone replacement therapy on bone mineral content in postmenopausal women Bone 19 IssueID5 191S–193S Occurrence Handle10.1016/S8756-3282(96)90164-7 Occurrence Handle8922661 Occurrence Handle1:CAS:528:DyaK28XnsVaktrc%3D
The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on bone mineral density. Results from the postmenopausal oestrogen/progestin interventions (PEPI) trial. JAMA 1996; 276: 1389–1396.
D Grady SM Rubin DB Petitti CS Fox D Black B Ettinger et al. (1992) ArticleTitleHormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1016–1036 Occurrence Handle1443971 Occurrence Handle1:STN:280:DyaK3s%2FntlensQ%3D%3D
P Maxim B Ettinger GM Spitalny (1995) ArticleTitleFracture protection provided by long-term estrogen treatment Osteoporos Int 5 23–29 Occurrence Handle10.1007/BF01623654 Occurrence Handle7703620 Occurrence Handle1:STN:280:DyaK2M3hvVelsA%3D%3D
S Høidrup M Gr¢nbæk AT Pedersen JB Lauritzen A Gottschau M Schroll (1999) ArticleTitleHormone replacement therapy and hip fracture risk–the effect modification by tobacco smoking, alcohol intake, physical activity and body mass index Am J Epidemiol 150 1085–1093 Occurrence Handle10568624
JA Cauley DG Seeley K Ensrud B Ettinger D Black SR Cummings (1995) ArticleTitleEstrogen replacement therapy and fractures in older women Ann. Intern. Med 122 9–16 Occurrence Handle7985914 Occurrence Handle1:STN:280:DyaK2M%2Fnslagtw%3D%3D
F Grodstein MJ Stampfer M Falkeborn T Naessén I Persson (1999) ArticleTitlePostmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women Epidemiology 10 476–480 Occurrence Handle10468418 Occurrence Handle1:STN:280:DyaK1Mzps1GhsA%3D%3D Occurrence Handle10.1097/00001648-199909000-00003
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative. Randomized controlled trial. JAMA 2002; 288: 321–333.
K Michaëlsson JA Baron BY Farahmand O Johnell C Magnusson P-G Persson et al. (1998) ArticleTitleHormone replacement therapy and risk of hip fracture: population based case–control study Br Med J 316 1858–1863
O Johnell B Gullberg JA Kanis E Allander A Elfors J Dequeker et al. (1995) ArticleTitleRisk factors for hip fracture in European women: The MEDOS Study J. Bone Miner Res 10 1802–1815 Occurrence Handle8592959 Occurrence Handle1:STN:280:DyaK287lsFKmtQ%3D%3D Occurrence Handle10.1002/jbmr.5650101125
SR Cummings MC Nevitt WS Browner K Stone CS Fox K Ensrud et al. (1995) ArticleTitleRisk factors for hip fracture in white women N Engl J Med 332 767–773 Occurrence Handle10.1056/NEJM199503233321202 Occurrence Handle7862179 Occurrence Handle1:STN:280:DyaK2M7ms1aktw%3D%3D
NOMESKO. Nordisk Ulykkesklassifikation. 8. 1987.
DJ Torgerson SEM Bell-Syser (2001) ArticleTitleHormone Replacement Therapy and prevention of nonvertebral fractures–A metaanalysis of randomized trials JAMA 285 2891–2897 Occurrence Handle10.1001/jama.285.22.2891 Occurrence Handle11401611 Occurrence Handle1:CAS:528:DC%2BD3MXkvVOnt74%3D
NS Weiss CL Ure JH Ballard R Williams Ann JR Daling (1980) ArticleTitleDecreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen N Engl J Med 303 1195–1198 Occurrence Handle7421945 Occurrence Handle1:STN:280:DyaL3M%2FjtVOluw%3D%3D Occurrence Handle10.1056/NEJM198011203032102
DP Kiel DT Felson JJ Anderson PWF Wilson MA Moskowitz (1987) ArticleTitleHip fracture and the use of estrogen in␣postmenopausal women. The Framingham study N␣Engl J Med 317 1169–1174 Occurrence Handle3657888 Occurrence Handle1:STN:280:DyaL1c%2FhsVSktw%3D%3D Occurrence Handle10.1056/NEJM198711053171901
DL Schneider EL Barrett-Connor DJ Morton (1997) ArticleTitleTiming of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernado Study. JAMA 277 543–547 Occurrence Handle9032160 Occurrence Handle1:CAS:528:DyaK2sXhvVSnsLc%3D Occurrence Handle10.1001/jama.277.7.543
E Løkkegaard SP Johnsen BL Heitmann C Stahlberg AT Pedersen EB Obel et al. (2004) ArticleTitleThe validity of self-reported use of hormone replacement therapy among Danish nurses Acta Obstet Gynecol Scand 83 476–481 Occurrence Handle15059162 Occurrence Handle10.1111/j.0001-6349.2004.00376.x
YA Hundrup EB Obel NK Rasmussen J Philip (2000) ArticleTitleUse of hormone replacement therapy among Danish nurses in 1993 Acta Obstet Gynecol Scand 79 194–201 Occurrence Handle10716300 Occurrence Handle1:STN:280:DC%2BD3c7nvFSntg%3D%3D Occurrence Handle10.1034/j.1600-0412.2000.079003194.x
YA Hundrup S Høidrup EB Obel (2004) ArticleTitleThe validity of self-reported fractures among Danish nurses: A comparison with fractures registered in the Danish National Hospital register Scand J Public Health 32 136–143 Occurrence Handle10.1080/14034940310017490 Occurrence Handle15255503
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hundrup, Y.A., Høidrup, S., Ekholm, O. et al. Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: The Danish Nurse Cohort Study. Eur J Epidemiol 19, 1089–1095 (2004). https://doi.org/10.1007/s10654-004-2173-y
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10654-004-2173-y